• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, October 23, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

ESMO emphasises importance of cancer on the global health agenda

Bioengineer by Bioengineer
May 24, 2018
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: © European Society for Medical Oncology

LUGANO, Switzerland, 24 May 2018 – At the 71st World Health Assembly (WHA) in Geneva, Switzerland, (1) ESMO, the leading professional organisation for medical oncology, delivered two statements positioning cancer as a priority on the World Health Organisation's (WHO) global agenda. Presenting its recommendations for action to the international community, ESMO advocated the strengthening of health systems to achieve Universal Health Coverage and to provide essential secondary healthcare services to the millions of cancer patients who die prematurely due to lack of access to appropriate treatment. In particular, ESMO called on the WHO to ensure that governments would be required to take specific actions in the interest of cancer control.

The widespread availability of secondary healthcare services to cancer patients – ESMO stressed at the WHA – depends on the presence of sufficient numbers of well-trained oncology professionals with sustainable access to the resources required to perform surgery, deliver radiotherapy, administer cancer treatments, and provide supportive and palliative care. ESMO is active in many of these areas and is able to support the individual efforts of Member States.

In a separate address, ESMO spoke out on the issue of shortages of medicines and reiterated its support to WHO initiatives in this field, including the Global Reporting System for monitoring the supply of essential cancer medicines. ESMO also voiced its agreement with the WHO's position that "investments in access to cancer medicines should be made where they offer the greatest value for money" and drew attention to the ESMO Magnitude of Clinical Benefit Scale (2), a tool designed to help health authorities prioritise the reimbursement of cancer medicines based on their potential to improve patient outcomes.

Dr Alexandru Eniu, Chair of the ESMO Global Policy Committee, underlined that, "ESMO has worked with the WHO for over 15 years to improve cancer care – not just in Europe, but worldwide. The platform we were given to talk about cancer at this year's WHA illustrates how prominent the topic is becoming on the global health agenda and confirms the relevance of our continued collaboration." ESMO congratulates the WHO as it celebrates its 70th anniversary and look forward to continuing the fruitful collaboration.

ESMO President Josep Tabernero added: "It was a privilege for us to be able to speak directly to the international community about the pressing global health issue that is cancer. ESMO is ready to support the WHO and its Member States in strengthening the medical oncology workforce and in identifying the most cost-effective interventions and treatments that can immediately help reduce the number of cancer deaths worldwide."

###

Notes to Editors

Watch the video "ESMO and WHO collaboration: 15 years together to improve cancer care": https://www.youtube.com/watch?v=Uu7MprOF2vc&feature=youtu.be

References

1 http://www.who.int/world-health-assembly/seventy-first The World Health Assembly is the decision-making body of the WHO and convenes annually to determine its policies based on a specific health agenda. As a non-State actor in official relations with the World Health Organisation, ESMO was invited to contribute to the WHA discussion in preparation of the third UN High-level Meeting of the General Assembly on the prevention and control of non-communicable diseases, to be held in September http://www.who.int/ncds/governance/third-un-meeting/en/

2 http://www.esmo.org/Policy/Magnitude-of-Clinical-Benefit-Scale

About the European Society for Medical Oncology (ESMO)

ESMO is the leading professional organisation for medical oncology. With 18,000 members representing oncology professionals from over 150 countries worldwide, ESMO is the society of reference for oncology education and information. We are committed to supporting our members to develop and advance in a fast-evolving professional environment. Visit http://www.esmo.org

Media Contact

ESMO Press Office
[email protected]
@myesmo

http://www.esmo.org

Original Source

http://esmo.org/Press-Office/Press-Releases/Cancer-Global-Health-Agenda-WHA

Share12Tweet7Share2ShareShareShare1

Related Posts

Tailoring Treatments: Pharmacokinetics of Molecules in Rheumatoid Arthritis

October 23, 2025

New Model Predicts Caregiver Distress in Dementia

October 23, 2025

Linking FSHR Polymorphisms to PCOS Traits

October 23, 2025

Scientists Uncover Hydrogen’s Crucial Role in the Gut

October 23, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1276 shares
    Share 510 Tweet 319
  • Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    307 shares
    Share 123 Tweet 77
  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    159 shares
    Share 64 Tweet 40
  • New Study Suggests ALS and MS May Stem from Common Environmental Factor

    132 shares
    Share 53 Tweet 33

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Psoriasis-Associated Gene Mutation Found to Affect Gut Health

Second-Gen Sequencing in Lung Cancer Immunotherapy

Tailoring Treatments: Pharmacokinetics of Molecules in Rheumatoid Arthritis

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 66 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.